Process View
Any process that activates or increases the frequency, rate or extent of cell junction assembly.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of cell junction assembly"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
S100A6 | S100 calcium binding protein A6 | 0.999 | Human | |
FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.995 | Human | |
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.991 | Human | |
S100A9 | S100 calcium binding protein A9 | 0.934 | Human | |
VEGFA | vascular endothelial growth factor A | 0.920 | ||
S100A8 | S100 calcium binding protein A8 | 0.890 | Human | |
S100B | S100 calcium binding protein B | 0.775 | Human | |
ANGPT2 | angiopoietin 2 | 0.734 | ||
PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.710 | Human | |
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.703 | Human | |
S100A4 | S100 calcium binding protein A4 | 0.691 | Human | |
ANXA2 | annexin A2 | 0.646 | ||
PTPRB | protein tyrosine phosphatase, receptor type, B | 0.441 | Human | |
S100A10 | S100 calcium binding protein A10 | 0.410 | ||
GAB1 | GRB2-associated binding protein 1 | 0.375 | ||
S100A1 | S100 calcium binding protein A1 | 0.360 | Human | |
FHL2 | four and a half LIM domains 2 | 0.325 | ||
ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.277 | ||
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.273 | ||
S100A11 | S100 calcium binding protein A11 | 0.241 | Human | |
RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.238 | ||
NCK2 | NCK adaptor protein 2 | 0.238 | ||
PTK2 | PTK2 protein tyrosine kinase 2 | 0.237 | ||
TSC2 | tuberous sclerosis 2 | 0.228 | ||
LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.216 | ||
PGF | placental growth factor | 0.205 | Human | |
PLCG1 | phospholipase C, gamma 1 | 0.139 | ||
CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.110 | Human | |
LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.105 | ||
AREG | amphiregulin | 0.099 | ||
NCF1 | neutrophil cytosolic factor 1 | 0.085 | ||
TMSB10 | thymosin beta 10 | 0.085 | ||
CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.080 | ||
CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.079 | ||
NCF2 | neutrophil cytosolic factor 2 | 0.077 | ||
PDGFA | platelet-derived growth factor alpha polypeptide | 0.076 | Human | |
LPXN | leupaxin | 0.076 | Human | |
LAT | linker for activation of T cells | 0.075 | ||
ANGPT1 | angiopoietin 1 | 0.072 | ||
EMP3 | epithelial membrane protein 3 | 0.064 | ||
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.056 | ||
DPYSL4 | dihydropyrimidinase-like 4 | 0.055 | ||
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.053 | ||
PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.048 | ||
HOXA1 | homeobox A1 | 0.045 | ||
GHR | growth hormone receptor | 0.043 | ||
FYN | FYN oncogene related to SRC, FGR, YES | 0.040 | ||
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.039 | ||
SMAD2 | SMAD family member 2 | 0.037 | ||
S100A2 | S100 calcium binding protein A2 | 0.036 | Human | |
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.032 | ||
RHOA | ras homolog gene family, member A | 0.032 | ||
TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.031 | ||
PDGFC | platelet derived growth factor C | 0.029 | ||
KITLG | KIT ligand | 0.026 | ||
LDLR | low density lipoprotein receptor | 0.025 | ||
LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.024 | ||
NRP1 | neuropilin 1 | 0.023 | ||
AGER | advanced glycosylation end product-specific receptor | 0.023 | ||
S100A12 | S100 calcium binding protein A12 | 0.022 | Human | |
PARVA | parvin, alpha | 0.022 | ||
ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.021 | ||
TRIP6 | thyroid hormone receptor interactor 6 | 0.021 | ||
RRAS | related RAS viral (r-ras) oncogene homolog | 0.020 | ||
CDC42EP1 | CDC42 effector protein (Rho GTPase binding) 1 | 0.019 | ||
S100P | S100 calcium binding protein P | 0.018 | Human | |
COL6A2 | collagen, type VI, alpha 2 | 0.017 | ||
FKBP4 | FK506 binding protein 4, 59kDa | 0.017 | ||
PHF21A | PHD finger protein 21A | 0.017 | ||
CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 0.016 | ||
CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 | 0.015 | ||
WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.015 | ||
TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.014 | Human | |
NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.014 | ||
UBE2R2 | ubiquitin-conjugating enzyme E2R 2 | 0.014 | ||
DPPA4 | developmental pluripotency associated 4 | 0.014 | ||
EGFR | epidermal growth factor receptor | 0.013 | ||
CD63 | CD63 molecule | 0.013 | ||
MAP3K11 | mitogen-activated protein kinase kinase kinase 11 | 0.013 | ||
CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.012 | ||
FEM1B | fem-1 homolog b (C. elegans) | 0.012 | ||
CAPG | capping protein (actin filament), gelsolin-like | 0.012 | ||
ANXA1 | annexin A1 | 0.011 | ||
MDFI | MyoD family inhibitor | 0.011 |